These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12871688)

  • 41. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.
    Miller WL; Garratt KN; Burritt MF; Lennon RJ; Reeder GS; Jaffe AS
    Eur Heart J; 2006 May; 27(9):1061-9. PubMed ID: 16481332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weak diagnostic performance of troponin, creatine kinase and creatine kinase-MB to diagnose or exclude myocardial infarction after successful resuscitation.
    Kruse JM; Enghard P; Schröder T; Hasper D; Kühnle Y; Jörres A; Storm C
    Int J Cardiol; 2014 May; 173(2):216-21. PubMed ID: 24636545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superiority of combined CK-MB and troponin I measurements for the early risk stratification of unselected patients presenting with acute chest pain.
    Meyer T; Binder L; Graeber T; Luthe H; Kreuzer H; Oellerich M; Buchwald AB
    Cardiology; 1998; 90(4):286-94. PubMed ID: 10085491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis.
    Nienhuis MB; Ottervanger JP; Bilo HJ; Dikkeschei BD; Zijlstra F
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):318-24. PubMed ID: 18288753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome.
    Kini AS; Lee PC; Mitre CA; Kim MC; Kamran M; Duffy ME; Marmur JD; Sharma SK
    Am J Med; 2003 Dec; 115(9):708-14. PubMed ID: 14693323
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between plaque characterization by CT angiography and post-procedural myocardial infarction in patients with elective stent implantation.
    Uetani T; Amano T; Kunimura A; Kumagai S; Ando H; Yokoi K; Yoshida T; Kato B; Kato M; Marui N; Nanki M; Matsubara T; Ishii H; Izawa H; Murohara T
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):19-28. PubMed ID: 20129526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac enzyme elevation after coronary revascularization.
    Plitt A; Dangas G
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):224-225. PubMed ID: 29405598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment modalities of non-ST-elevation acute coronary syndromes in the real world. Results of the prospective R.OS.A.I.-2 registry.
    Registro Osservazionale Angina Instabile Investigators
    Ital Heart J; 2003 Nov; 4(11):782-90. PubMed ID: 14699708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.
    Harada Y; Koskinas KC; Ndrepepa G; Räber L; Braun S; Zanchin T; Kufner S; Hunziker L; Byrne RA; Heg D; Kastrati A; Windecker S
    Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):480-486. PubMed ID: 29292015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.
    Mehta V; Sukhija R; Mehra P; Goyal A; Yusuf J; Mahajan B; Gupta VK; Tyagi S; Palaniswamy C; Aronow WS
    Indian Heart J; 2016; 68(1):57-62. PubMed ID: 26896268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic efficacy of troponin T measurement in angina pectoris.
    Yang Z; Zhang W; Liu Y
    Chin Med J (Engl); 1995 Aug; 108(8):626-30. PubMed ID: 7587497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.